Pharmacopsychiatry 1990; 23(3): 113-117
DOI: 10.1055/s-2007-1014492
© Georg Thieme Verlag KG Stuttgart · New York
Validity of Imipramine Platelet Binding Sites as a Biological Marker of Endogenous Depression
A World Health Organization Collaborative StudyE. Mellerup1
, S. Z. Langer2
-
1Copenhagen
-
2Paris
-
Athens, Greece: C.Stefanis, V. Alevizos - Eginition Hospital,Athens
Basel, Switzerland: P. Kielholz (head), M. Gastpar, C. Gentsch, Gastpar G. - Psychiatrische Universitätsklinik Basel
Brussels ,Belgium:J. Mendlewicz - Cliniques Universitaire de Bruxelles
Copenhagen, Denmark: E. Mellerup, P. Bech, L. Eplov, P. Plenge - Psychochemistry Institute
Irvine, CA. USA, Irvine:E. DeMet (principle investigator), K. Bell, C. Reist, J. Wu, S. Potkin, W. E. Bunney Jr. -
University of California Irvine
Milan/Naples: D. Kemali, M. Maj (Naples), G.Racagni (Milan), with assistance of N. Brunello (Milan), L. Ravizza,
F. Bogelto (Turin), A. C. Altamura, M. Mauri (Milan), M. Casacchia, A. Rossi (L 'Aquila), V. Rapisarda, M. G.
Sotera (Catania) - Istituto di Psicologia Medica e Psichiatria, Naples/Institute of Pharmacology and
Pharmacognosy, Milan
Moscow: M. Vartanian, G. P. Panteleeva, O. S. Brusov, B. C. Belaiev, A. B. Katasonov - All Union Research Centre
of Mental Health
Munich, FRG: H. Hippius, B. Bondy - Psychiatrische Klinik und Poliklinik
Paris,France: S. Z. Langer - Synthelabo Recherche (LERS)
Tokyo, Japan: S. Yoshimoto, M. Nankai, K. Tshii, R. Takahashi - Department of Neuropsychiatry, Tokyo Medical
and Dental University
T. Ngo Khac, P. Morozov, L. L. Prilipko - Division of Mental Health, World Health Organization, Geneva,
Switzerland
